EVIDENCE-BASED MEDICAL MONITORING
Author: Paul Glasziou, Les Irwig, Jeffrey Aronson
Publisher: Wiley-Blackwell
Publication Date: 2008
Publisher: Wiley-Blackwell
Publication Date: 2008
ISBN 10: 1405153997
ISBN 13: 9781405153997
Edition: 1st
ISBN 13: 9781405153997
Edition: 1st
Description:
This book discusses how monitoring principles adopted in other spheres such as clinical pharmacology and evidence-based medicine can be applied to chronic disease in the global setting. With contributions from leading experts in evidence-based medicine, it will be a ground-breaking text for all involved in delivery of better and more effective management of chronic illnesses.
Table of Contents
Front Matter
PART 1 The Theory of Monitoring
- 7.1. Reference change value (critical difference)
- 7.2. Statistical process control (SPC)
- 7.3. Control charts
- 7.4. Graphical displays for individual measurements
- 7.5. Improved criteria for identifying special-cause variability
- 7.6. Target (specification) limits
- 7.7. Underlying assumptions
- 7.8. Conclusions
- References
- 8.1. Characteristics of surrogate markers and outcomes
- 8.2. The effect of the disease or treatment stage on monitoring frequency
- 8.3. Scheduling tests when results are outside control or specification limits
- 8.4. Cost-effectiveness
- 8.5. Further research and application of work on monitoring frequency
- 8.6. Conclusions
- References
- 11.1. The social and psychological effects of monitoring
- 11.2. Social and psychological benefits and harms of monitoring
- 11.3. Adopting a shared decision-making approach in monitoring
- 11.4. Patient adherence to agreed monitoring regimens and health-care advice
- 11.5. Measuring social and psychological outcomes of monitoring
- 11.6. Conclusions: future directions
- Acknowledgements
- References
An introduction to monitoring therapeutic interventions in clinical practice
A framework for developing and evaluating a monitoring strategy
Developing monitoring tools: integrating the pathophysiology of disease and the mechanisms of action of therapeutic interventions
Biomarkers and surrogate endpoints in monitoring therapeutic interventions
Choosing the best monitoring tests
Monitoring the initial response to treatment
Control charts and control limits in long-term monitoring
Developing a monitoring schedule: frequency of measurement
How should we adjust treatment?
Monitoring as a learning and motivational tool
Monitoring from the patient’s perspective: the social and psychological implications
Evaluating the effectiveness and costs of monitoring
Good practice in delivering laboratory monitoring
Point-of-care testing in monitoring
Monitoring for the adverse effects of drugs
PART 2 The Practice of Monitoring
- 16.1. The condition
- 16.2. Why do we monitor?
- 16.3. Particular challenges
- 16.4. Potential measures and a causal schema
- 16.5. Blood glucose concentration measurement
- 16.6. Glycated haemoglobin measurement
- 16.7. Symptoms, urine monitoring and fructosamine
- 16.8. Choosing measures for monitoring
- 16.9. Monitoring schedules
- 16.10. Self-monitoring
- 16.11. Future research
- References
- 19.1. Primary hypothyroidism
- 19.2. Treatment of hypothyroidism
- 19.3. Rationale for monitoring treatment in primary hypothyroidism
- 19.4. Relation between the pathophysiology of hypothyroidism, the mechanism of action of levothyroxine replacement and the development of a monitoring schedule
- 19.5. Test selection for monitoring thyroxine replacement therapy
- 19.6. Setting treatment targets for levothyroxine replacement
- 19.7. Developing a thyroid monitoring schedule
- 19.8. Evaluating the effectiveness of thyroid monitoring
- Acknowledgements
- References